Q-Cells SE (FRA:QCE) Q-Cells SE / Directors' dealings: Correction Directors' Dealings announcement from November 26, 2008 Director's Dealings announcement according to §15a WpHG (the German Securities Trading Act) processed and transmitted by Hugin. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------



-------------------------------------------------------------------------------- Details of the person subject to the disclosure requirement --------------------------------------------------------------------------------

Dr. Hartmut Schüning

Person with executive functions - Member of a managing body

Member of board

-------------------------------------------------------------------------------- Designation of the financial instrument --------------------------------------------------------------------------------

ISIN..........................: DE000A0LMY64 Designation...................: Exchangeable Bond 1.375% Q-Cells Int. Fin. CV

The nominal value of the exchangeable bond is 100,000.00 EUR

-------------------------------------------------------------------------------- Details of the transaction --------------------------------------------------------------------------------

Type of transaction...........: Buy Date..........................: 25.11.2008 Place (stock exchange)........: Stuttgart Price.........................: 55.770,00 Currency......................: EUR Quantity......................: 1 Business volume...............: 55.770,00 EUR

Correction of the announcement from November 26, 2008: The price paid for the exchangeable bond was 55,770.00 EUR and not 55,700.00 EUR.

Q-Cells SE OT Thalheim, Guardianstr. 16 Bitterfeld-Wolfen 06766 Germany

Index: - CDAX - GEX - Prime All Share - TecDAX Listed: - Freiverkehr in Bayerische Börse München - Freiverkehr in Börse Berlin - Freiverkehr in Börse Düsseldorf - Freiverkehr in Börse Stuttgart - Amtlicher Markt in Frankfurter Wertpapierbörse - Prime Standard in Frankfurter Wertpapierbörse - Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg

--- End of Message ---

Q-Cells SE OT Thalheim, Guardianstr. 16 Bitterfeld-Wolfen Germany

WKN: 555866; ISIN: DE0005558662; Index: CDAX, GEX, Prime All Share, TecDAX; Listed: Amtlicher Markt in Frankfurter Wertpapierbörse, Prime Standard in Frankfurter Wertpapierbörse, Freiverkehr in Bayerische Börse München, Freiverkehr in Börse Berlin,

Freiverkehr in Börse Düsseldorf, Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg, Freiverkehr in Börse Stuttgart;

Q-Cells SE

http://www.q-cells.com

ISIN: DE0005558662

Stock Identifier: XFRA.QCE

Verbundene Unternehmen

Q-Cells AG

ABN Newswire Diese Seite wurde besucht:  (letzten 7 Tagen: 12) (letzten 30 Tagen: 31) (seit Veröffentlichung: 2343)